With the analysis among 104 patents, we discovered top 34 key players by total patent application. Nerviano Medical Sciences S.r.l, Glaxosmithkline Intellectual Property Development Ltd., Sumitomo Pharma Oncology, Inc. are dominant in this area. They take 48.08% of the total patent filing.
Nerviano Medical Sciences S.r.l
Glaxosmithkline Intellectual Property Development Ltd.
East Sussex, United Kingdom
Patent: 12
Sumitomo Pharma Oncology, Inc.
Massachusetts, United States
Patent: 7
Sumitomo Dainippon Pharma Oncology, Inc.
Akershus, Norway
Patent: 4
Millennium Pharmaceuticals, Inc.
Massachusetts, United States
Patent: 3
New Jersey, United States
Patent: 2
California, United States
Patent: 2
With the analysis among 8 patents, we discovered top 3 start-ups by total patent application.
Sumitomo Dainippon Pharma Oncology, Inc.
Utah, United States
Patent: 2
Shenzhen Tajirui Biomedical Co. Ltd.
Guangdong Sheng, China
Patent: 2
With the analysis among related 31 patents applied in the last 5 years. We discover 11 most active companies in this area. The fast-growing Glaxosmithkline Intellectual Property Development Ltd., Sumitomo Pharma Oncology, Inc., Nerviano Medical Sciences S.r.l take 61.29% of patent filing during this period.
Glaxosmithkline Intellectual Property Development Ltd.
East Sussex, United Kingdom
Patent: 12
Sumitomo Pharma Oncology, Inc.
Massachusetts, United States
Patent: 4
Nerviano Medical Sciences S.r.l
Utah, United States
Patent: 2
Shanghai Haihe Pharmaceutical Research & Development Co., Ltd.
Shanghai Shi, China
Patent: 2
Shanghai Institute of Materia Medica Chinese Academy of Sciences
Shanghai Shi, China
Patent: 2
Shenzhen Tajirui Biomedical Co. Ltd.
Guangdong Sheng, China
Patent: 2
eFFECTOR Therapeutics Operations, Inc.
California, United States
Patent: 2
Tolero Pharmaceuticals, Inc.
Utah, United States
Patent: 1
Mazowieckie, Poland
Patent: 1
With the analysis among related 31 patents in last 5 years, we discover 8 new entrants. Glaxosmithkline Intellectual Property Development Ltd., Halia Therapeutics, Inc., Shanghai Haihe Pharmaceutical Research & Development Co., Ltd. are the most active new entrants in this area.
Glaxosmithkline Intellectual Property Development Ltd.
East Sussex, United Kingdom
Patent: 12
Utah, United States
Patent: 2
Shanghai Haihe Pharmaceutical Research & Development Co., Ltd.
Shanghai Shi, China
Patent: 2
Shanghai Institute of Materia Medica Chinese Academy of Sciences
Shanghai Shi, China
Patent: 2
Shenzhen Tajirui Biomedical Co. Ltd.
Guangdong Sheng, China
Patent: 2
eFFECTOR Therapeutics Operations, Inc.
California, United States
Patent: 2
Mazowieckie, Poland
Patent: 1
Yaojie Ankang Nanjing Technology Co Ltd.
Jiangsu Sheng, China
Patent: 1
With the analysis among 3 patents, we discovered top 2 universities and scientific research institutions by total patent application.
Shanghai Institute of Materia Medica Chinese Academy of Sciences
Shanghai Shi, China
Patent: 2